Kyntra Bio share price logo

Kyntra Bio

NASDAQ: KYNB

$7.95

+0.17

(+2.19%)

as on

Kyntra Bio Stock Performance

as on September 2, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $7.80
    $8.04
    downward going graph

    1.89%

    Downside

    1.13%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Kyntra Bio share price movements today

Previous Close
$7.78
Open
$7.83
Volume
602.1K
Market Cap
$31.5M
Day's Low - High
$7.80 - $8.04

Kyntra Bio Historical Returns

1 Month Return
+ 18.13 %
3 Month Return
+ 16.23 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Kyntra Bio Stock Fundamentals & Key Indicators

Check Kyntra Bio market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$31.5M

EPS (TTM)

58.19

Dividend Yield

0.00%

PE Ratio (TTM)

0.14

Industry PE ratio

-1.4626335877862595

PEG Ratio

0.00003657822314086449

Return On Equity TTM

-605.53%

Kyntra Bio Stock Valuation

Track how Kyntra Bio P/E has moved over time to understand its valuation trends.

Kyntra Bio in the last 5 years

  • Overview

  • Trends

Lowest (-127.63x)

December 31, 2022

Industry (-1.46x)

December 31, 2025

Today (0.19x)

December 31, 2025

Highest (0.19x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: 0.19x

Kyntra Bio vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kyntra Bio with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$31.5MNA0.1418.15%NA
BUY$44.6B614.61%NA0.00%NA
BUY$137.9B174.9%31.9286.04%NA
BUY$61.6B-61.21%-7.98-12.57%NA
BUY$82.3B21.91%19.984.86%0.44%

Analyst Recommendation on Kyntra Bio Stock

Based on 4 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 4 analysts, 75% of analysts recommend a 'BUY' rating for Kyntra Bio. Average target price of $36

Indian Investors' Interest in Kyntra Bio Stock

Search interest for Kyntra Bio Stock has increased by 10% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:10% versus previous 30 day period

Kyntra Bio Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
25
0
46
-123
2
1
1
1
3
-1
Gross Profit
-32
-31
41
-102
2
1
0
1
0
-1
Operating Income
-49
-46
-16
-91
-14
-11
-5
-14
-13
-17
EBITDA
-46
-44
-12
-91
-14
-11
-10
-20
-12
-49
Interest Expense
2
1
4
-
2
2
2
2
2
2
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-49
-47
-17
-87
-16
-13
-13
-14
-15
11
Income Tax Expense
0
0
0
0
0
0
-
-
-
0
Net Income
-32
-15
-17
17
4
-7
148
37
-15
11
Net Profit Margin
-128.01%
-3156.51%
88.57%
83.23%
78.86%
77.30%
87.55%
136.26%
-9.84%
100.14%

Kyntra Bio Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
125
212
256
176
235
140
46
29
6
Gross Profit
-70
-22
255
167
-213
120
42
14
5
Operating Income
-122
-86
-89
-191
-288
-301
-322
-150
-45
EBITDA
-104
-68
-52
-164
-333
-282
-305
-142
-57
Interest Expense
9
10
2
2
1
1
8
8
8
Depreciation
6
6
21
22
14
10
9
2
0
Income Before Tax
-125
-86
-76
-188
-289
-293
-323
-153
-58
Income Tax Expense
0
0
0
0
0
0
0
0
0
Net Income
-126
-86
-76
-189
-290
-293
-284
-47
183
Net Profit Margin
-56.38%
-10.74%
99.55%
94.97%
-90.89%
85.59%
91.53%
47.47%
91.37%

Kyntra Bio Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-32
-15
-17
17
4
-7
200
-14
-15
11
Operating Cash Flow
-59
-39
-8
-30
2
12
-1
-18
-13
-3
Investing Cash Flow
51
72
0
1
0
0
87
-51
3
17
Financing Cash Flow
0
0
0
0
0
0
-85
0
0
0
Change in Cash
-7
34
-9
-28
4
13
-1
-70
-10
13

Kyntra Bio Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-120
-86
-76
-189
-290
-293
-284
-47
183
Operating Cash Flow
-66
-76
-78
81
-82
-145
-315
-137
-4
Investing Cash Flow
69
-522
120
452
-426
89
153
125
35
Financing Cash Flow
496
13
-4
13
0
46
122
0
-86
Change in Cash
499
-584
37
552
-507
-15
-42
-11
-54

Mutual Funds that own Kyntra Bio Stock

Check out the Mutual Funds with significant holdings in Kyntra Bio.

Funds
Holdings
Shares Held
T. ROWE PRICE QUANTITATIVE MANAGEMENT FUNDS, INC.
10.407189%
421400
Fidelity Commonwealth Trust II
4.185571%
169479
VANGUARD INDEX FUNDS
3.867676%
156607
TIAA-CREF Funds
2.052098%
83092
Northern Funds
0.916519%
37111

Global Institutional Holdings in Kyntra Bio

Funds
Holdings
Vanguard
3.86%
Theofanis Kolokotrones
1.45%

Kyntra Bio News & Key Events

  • img

    Today's Timeline - 31 August

    Tue, 03:22 AM

    -

    Kyntra Bio amends royalty agreement, reducing max payments from $125M to $65M and making a $42.6M upfront payment.

Insights on Kyntra Bio

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -15.19M → 11.97M (in $), with an average increase of 226.9% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, KYNB stock has moved up by 18.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 537.7% return, outperforming this stock by 572.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 37.1% return, outperforming this stock by 107.1%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 3.73M → -1.47M (in $), with an average decrease of 139.4% per quarter

About Kyntra Bio

Kyntra Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing FG-3246, a potential antibody-drug conjugate targeting CD46, for the treatment of metastatic castration-resistant prostate cancer and other cancers. It is also developing Roxadustat, a small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. The company was formerly known as FibroGen, Inc. and change its name to Kyntra Bio, Inc. in January 2026. Kyntra Bio, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.
OrganisationKyntra Bio
Headquarters350 Bay Street, San Francisco, CA, United States, 94133
IndustryBiotechnology
CEOMr. Thane Wettig
E-voting on sharesClick here to vote

Key Management of Kyntra Bio

Name

Title

Ms. Michelle Simonetti

Head of People and Culture & Executive Director

Ms. Gaia Vasiliver-Shamis

Director of IR & Communications - LifeSci Advisors

Mr. Thane Wettig

CEO & Director

Mr. David DeLucia

Senior VP & CFO

Mr. John Alden

Corporate Secretary & General Counsel

FAQs

What is Kyntra Bio share price today?

Kyntra Bio share price today is $7.95 as on at the close of the market. Kyntra Bio share today touched a day high of $8.04 and a low of $7.80.

What is the 52 week high and 52 week low for Kyntra Bio share?

Kyntra Bio share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Kyntra Bio stock price today i.e. is closed at $7.95,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Kyntra Bio's market capitalisation today?

Kyntra Bio market capitalisation is $0.00T as on .

How to invest in Kyntra Bio Stock (KYNB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Kyntra Bio on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kyntra Bio Shares that will get you 0.1887 shares as per Kyntra Bio share price of $7.95 per share as on September 2, 2026 at 8:45 am IST.

What is the minimum amount required to buy Kyntra Bio Stock (KYNB) from India?

Indian investors can start investing in Kyntra Bio (KYNB) shares with as little as ₹94.96 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in Kyntra Bio stock (as per the Rupee-Dollar exchange rate as on ). Based on Kyntra Bio share’s latest price of $7.95 as on September 2, 2026 at 8:45 am IST, you will get 1.2579 shares of Kyntra Bio. Learn more about fractional shares .